Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorČiginskienė, Aušra
dc.contributor.authorDambrauskienė, Asta
dc.contributor.authorRello Condomines, Jordi
dc.contributor.authorAdukauskienė, Dalia
dc.date.accessioned2019-03-22T13:03:38Z
dc.date.available2019-03-22T13:03:38Z
dc.date.issued2019-02-13
dc.identifier.citationČiginskienė A, Dambrauskienė A, Rello J, Adukauskienė D. Ventilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality. Medicina (Kaunas). 2019; 55(2): 49.
dc.identifier.issn1010-660X
dc.identifier.urihttp://hdl.handle.net/11351/3860
dc.descriptionA. baumannii; Mortality; Ventilator-associated pneumonia (VAP)
dc.description.abstractBackground and objectives: High mortality and healthcare costs area associated with ventilator-associated pneumonia (VAP) due to Acinetobacter baumannii (A. baumannii). The data concerning the link between multidrug-resistance of A. baumannii strains and outcomes remains controversial. Therefore, we aimed to identify the relation of risk factors for ventilator-associated pneumonia (VAP) and mortality with the drug resistance profiles of Acinetobacter baumannii (A. baumannii) and independent predictors of in-hospital mortality. Methods: A retrospective ongoing cohort study of 60 patients that were treated for VAP due to drug-resistant A. baumannii in medical-surgical intensive care units (ICU) over a two-year period was conducted. Results: The proportions of multidrug-resistant (MDR), extensively drug-resistant (XDR), and potentially pandrug-resistant (pPDR) A. baumannii were 13.3%, 68.3%, and 18.3%, respectively. The SAPS II scores on ICU admission were 42.6, 48.7, and 49 (p = 0.048); hospital length of stay (LOS) prior to ICU was 0, one, and two days (p = 0.036), prior to mechanical ventilation (MV)-0, 0, and three days (p = 0.013), and carbapenem use prior to VAP-50%, 29.3%, and 18.2% (p = 0.036), respectively. The overall in-hospital mortality rate was 63.3%. In MDR, XDR, and pPDR A. baumannii VAP groups, it was 62.5%, 61.3%, and 72.7% (p = 0.772), respectively. Binary logistic regression analysis showed that female gender (95% OR 5.26; CI: 1.21⁻22.83), SOFA score on ICU admission (95% OR 1.28; CI: 1.06⁻1.53), and RBC transfusion (95% OR 5.98; CI: 1.41⁻25.27) were all independent predictors of in-hospital mortality. Conclusions: The VAP risk factors: higher SAPS II score, increased hospital LOS prior to ICU, and MV were related to the higher resistance profile of A. baumannii. Carbapenem use was found to be associated with the risk of MDR A. baumannii VAP. Mortality due to drug-resistant A. baumannii VAP was high, but it was not associated with the A. baumannii resistance profile. Female gender, SOFA score, and RBC transfusion were found to be independent predictors of in-hospital mortality.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesMedicina;55(2)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectPneumònia - Mortalitat
dc.subjectInfeccions nosocomials
dc.subjectResistència als medicaments
dc.subject.meshPneumonia, Ventilator-Associated
dc.subject.mesh/mortality
dc.subject.meshBacterial Infections
dc.subject.meshDrug Resistance
dc.titleVentilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/medicina55020049
dc.subject.decsneumonía asociada al ventilador
dc.subject.decs/mortalidad
dc.subject.decsinfecciones bacterianas
dc.subject.decsresistencia a medicamentos
dc.relation.publishversionhttps://www.mdpi.com/1010-660X/55/2/49
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Čiginskienė A] Department of Intensive Care, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania. [Dambrauskienė A] Infection Control Service, Medical Academy, Lithuanian University of Health Science, Kaunas, Lithuania. [Rello J]Servei de Cures Intensives, Hospital Universitari Vall d'Hebron, Barcelona, Spain. CIBERES, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Vall d’Hebron Institut de Recerca, Barcelona, Spain. [Adukauskienė D] Department of Intensive Care, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
dc.identifier.pmid30781896
dc.identifier.wosWOS:000460170700032
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record